FCMV
IDYA icon

Foresite Capital Management VI’s IDEAYA Biosciences IDYA Stock Holding History

Foresite Capital Management VI’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-144,468
Closed -$3.04M – 17
2025
Q2 		$3.04M Buy
+144,468
New +$2.77M 1.71% 16

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Foresite Capital Management VI's IDYA Position: Q3 2025 in Review

Foresite Capital Management VI sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 144,468 shares — an estimated $3.04M sold.

Foresite Capital Management VI first reported a position in IDYA in Q2 2025 and held it in 1 quarter. The position peaked at $3.04M in Q2 2025. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Foresite Capital Management VI reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Foresite Capital Management VI sold 144,468 IDEAYA Biosciences shares in Q3 2025, an estimated $3.04M.
  • Foresite Capital Management VI first reported a position in IDEAYA Biosciences in Q2 2025 and held it in 1 quarter.
  • Foresite Capital Management VI's IDEAYA Biosciences position peaked at $3.04M in Q2 2025.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Foresite Capital Management VI's 13F filing for Q3 2025, filed 14 Nov 2025.